News and Comments


  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...

Recent Postings



Jazz Pharmaceuticals (JAZZ) Tysabri Roche (ROCHE) Elan (ELN) Revlimid (lenolidamide) Inovio (INO) Ridaforolimus Rapamune INNOVIVA (INVA) Idenix (IDIX) Trastuzumab-DM1 Biogen Idec (BIIB) Sarepta (SRPT) Illumina (ILMN) Ziofpharm (ZIOP) Theravance (THRX) Alnylam (ALNY) Bristol-Myers Squibb (BMY) Advaxis (ADXS) Human Longevity (HLI) Pluristem (PSTI) OSI (OSIP) SUNESIS PHARMACEUTICALS (SNSS) Adaptimmune (ADAP) Ocular Therapeutix (OCUL) Velcade (bortezomib) Sangamo (SGMO) PTC Therapeutics (PTCT) Aimmune Therapeutics (AIMT) Herceptin Cytokinetics (CYTK) Micromet (MITI) Regeneron (REGN) Galena (GALE) Incyte (INCY) Sequenom (SQNM) TOKAI (TKAOI) Prolor Biotech (PBTH) Valeant Pharmaceuticals International (VRX) ARGOS (ARGS) Auspex (ASPX) Alder Biopharmaceuticals (ALDR) Mirati Therapeutics (MRTX) galapagos (GLPG) C4 Therapeutics SERES THERAPEUTICS (MCRB) Onyx (ONXX) ACADIA (ACAD) PORTOLA (PTLA) VANDA (VNDA) Merck (MRK) IDERA (IDRA) NANTKWEST (NK) Anadys (ANDS) SYNTA (SNTA) Editas (EDIT) Multiple Myeloma JUNO (JUNO) CEMPRA (CEMP) Intermune (ITMN) Dynavax (DVAX) ABBVIE (ABBV) Sanofi-Aventis (SAN) Intercept (ICPT) Xoma (XOMA) REGULUS (RGLS) Global Cell Therapeutics (GBT) GUARDIAN HEALTH Exelixis (EXEL) Agenus (AGEN) Gilead (GILD) Sanofi (SNA) Bellicum (BLCM) Vitae Pharmaceuticals (VTAE) BIOMARIN (BMRN) ARCA (ABIO) Agenus (AGEN Array Pharmaceuticals (ARRY) Biocryst (BCRX) Telaprevir Zerenex Human Genome Sciences (HGSI) HALOZYME (HALO) ZALTRAP™ Amgen (AMGN) Ionis (IONS) Endometrial Cancer NOVOCURE (NVCR) ImmunoGen (IMGN) CRISPR Therapeutics (CRSP) Seattle Genetics (SGEN) KERYX (KERX) AGOS (ARGS) Benlysta (belimumab) AstraZeneca (AZN) Ariad (ARIA) Prosensa (RNA) NEKTAR (NKTR)) Spike Therapeutics (ONCE) Anacor (ANAC) GlaxoSmithKline (GSK) ISIS (ISIS) Dendreon (DNDN) CompuGen (CGEN) AERIE PHARMACEUTICALS Roche (RHHBY) Intrexon (XON) Vertex (VRTX) Genentech ADVENTRIX (ANX) MODERNA Sanofi (SNY) Abbott Laboratories (ABT) Theravance Bio Pharma (TBPH) KITE (KITE) RenenxBio (RGNX)